COVID-19 blood plasma therapy ineffective in severely ill patients
• New Atlas - Rich HaridyEarly findings from a large international clinical trial suggest severely ill COVID-19 patients do not benefit from an experimental therapy involving infusions of blood plasma from those who have recovered from the disease. This particular arm of the
